NEW DELHI, India — Russia’s sovereign wealth fund announced a manufacturing deal with the Indian pharmaceutical maker Virchow Biotech Private Limited for making 200 million doses of the Sputnik V vaccine each year.
This is the fourth manufacturing deal announced by Russia, and 700 million doses of the Russian vaccine will now be made in India.
Last week, two manufacturing deals for the vaccine in India were announced: Gland Pharma Pvt Ltd., a subsidiary of Chinese pharmaceutical company Fosun Pharma, said Tuesday it would 252 million doses vaccine and Stelis Biopharma partnered to produce and supply 200 million doses of the vaccine. Earlier, a deal to make 100 million doses of the vaccine annually was announced by Indian pharmaceutical firm Hetero Biopharma.
India has been pledged 125 million doses of the vaccine by Russia.